What is the average price target for NEURONETICS INC (STIM) stock?
9 analysts have analysed STIM and the average price target is 6.63 USD. This implies a price increase of 411.97% is expected in the next year compared to the current price of 1.295.
NEURONETICS INC (STIM) Forecast, Price Target & Analyst Ratings
NASDAQ:STIM • US64131A1051
Current stock price
1.295 USD
+0.02 (+1.97%)
At close:
1.3091 USD
+0.01 (+1.09%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEURONETICS INC (STIM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.11
- Revenue Estimate
- 41.48M
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.63
Upside
+ 411.97%
From current price of $1.30 to mean target of $6.63, Based on 9 analyst forecasts
Low
$5.56
Median
$7.14
High
$7.35
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for STIM. The average price target is 6.63 USD. This implies a price increase of 411.97% is expected in the next year compared to the current price of 1.295.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.22%
STIM was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about STIM.
In the previous month the buy percentage consensus was at a similar level.
STIM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-05 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-05-14 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023-05-10 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | Canaccord Genuity | Maintains | Buy |
| 2021-10-14 | JMP Securities | Maintains | Market Outperform |
| 2021-10-13 | BTIG | Downgrade | Buy -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.11
- Revenue Estimate
- 41.48M
- Revenue Q2Q
- 84.41%
- EPS Q2Q
- 67.03%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
STIM is expected to report earnings on 3/17/2026. The consensus EPS estimate for the next earnings is -0.11 USD and the consensus revenue estimate is 41.48M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 65.21M 17.90% | 71.348M 9.41% | 74.89M 4.96% | 151.03M 101.67% | 167.45M 10.87% | 187.99M 12.27% | 216.24M 15.03% | 242.25M 12.03% | |
| EBITDA YoY % growth | -33.46M -26.26% | -28.548M 14.68% | -28.49M 0.20% | -21.318M 25.17% | -11.526M 45.93% | -8.364M 27.43% | -6.63M 20.73% | -2.856M 56.92% | |
| EBIT YoY % growth | -35.11M -27.39% | -30.554M 12.98% | -30.563M -0.03% | -32.406M -6.03% | -24.688M 23.82% | -19.213M 22.17% | -17.646M 8.16% | -16.218M 8.09% | |
| Operating Margin | -53.84% | -42.82% | -40.81% | -21.46% | -14.74% | -10.22% | -8.16% | -6.69% | |
| EPS YoY % growth | -1.38 -14.92% | -1.07 22.41% | -1.37 -28.04% | -0.61 55.83% | -0.47 22.47% | -0.33 28.98% | -0.02 93.88% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 67.03% | -0.13 36.86% | -0.12 18.40% | -0.12 8.46% | -0.10 6.25% | -0.08 38.46% | -0.08 33.33% | -0.08 31.43% | -0.09 10.00% |
| Revenue Q2Q % growth | 41.48M 84.41% | 37.978M 18.77% | 42.636M 11.88% | 41.922M 12.40% | 44.982M 8.44% | 42.483M 11.86% | 46.665M 9.45% | 46.767M 11.56% | 50.439M 12.13% |
| EBITDA Q2Q % growth | -1.938M 64.10% | -4.284M 57.60% | -3.468M 44.48% | -3.06M 33.81% | -714K 63.16% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.481M 26.64% | -7.869M 28.55% | -6.37M 20.95% | -5.959M 18.61% | -4.49M 18.10% | -4.22M 46.38% | -4.88M 23.39% | -4.804M 19.38% | -5.142M -14.53% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.66%
EPS Next 5 Year
18.70%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
36.66%
Revenue Next 5 Year
26.89%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
19.86%
EBIT Next 5 Year
13.76%
NEURONETICS INC / STIM Forecast FAQ
When does NEURONETICS INC (STIM) report earnings?
NEURONETICS INC (STIM) will report earnings on 2026-03-17, before the market open.
Can you provide the consensus estimates for NEURONETICS INC next earnings?
The consensus EPS estimate for the next earnings of NEURONETICS INC (STIM) is -0.11 USD and the consensus revenue estimate is 41.48M USD.
What is the expected long term growth rate for NEURONETICS INC (STIM)?
The expected long term growth rate for NEURONETICS INC (STIM) is 36.66%.